Biotechs Get Wall Street Nod on New Blood Disorder Drugs Data

(Bloomberg) -- Biotechnology stocks initially moved higher as Wall Street cheered updates for a range of therapies to treat blood disorders like sickle cell disease and beta thalassemia.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.